Topics

Companies Related to "High throughput reformatting phage displayed antibody fragments IgGs" [Most Relevant Company Matches] RSS

23:16 EDT 22nd July 2019 | BioPortfolio

Here are the most relevant search results for "High throughput reformatting phage displayed antibody fragments IgGs" found in our extensive corporate database of over 50,000 company records.

Showing "High throughput reformatting phage displayed antibody fragments IgGs" Companies 1–25 of 4,700+

Extremely Relevant

ESBATech AG

ESBATech AG is a Zurich, Switzerland-based, privately held drug discovery and development company focused on advancing antibody fragments for therapeutic applications. The company applies its proprietary, fully human single-chain antibody frameworks to generate product candidates against targets of clinical relevance. ESBATech is focused on delivering high concentrations of its therapeutic ant...


Relevant

Actigen

ACTIGEN Ltd is an emerging biotechnology company engaged in the development and marketing of novel tools for the research, diagnostic and bioseparations market.ACTIGEN's lead product is recombinant Protein L (rProtein L?) which binds antibodies and antibody fragments with high specificity, enabling their efficient purification against a background of significant contamination with other proteins. ...

Crescendo Biologics Ltd

Crescendo Biologics will apply highly innovative antibody fragment technologies to the development of new targeted therapeutics. The Crescendo transgenic mouse platform under development has the potential to rapidly and predictably generate high-affinity human heavy chain antibodies that readily yield VH fragments that have no requirement for humanisation. This is combined with a powerful in v...


4-Antibody AG

4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform, which is generating an emerging pipeline of antibody therapeutics.  The proprietary discovery engine is the in-vitro Retrocyte Display® technology, a fast and highly efficient source of antibody drug candidates.  Retrocyte Display generates high quality therapeutic ant...

Protos ImmunoResearch

specialising in antibody fab fragments

GeneTel Laboratories

GeneTel Laboratories provides quality research reagents, lab plastic wares, antibody products and high-throughput proteomic antibody production services to the global life science research and biotech as well as pharmaceutical industries. The company combines high quality custom services with large-scale generation of antibodies against deduced peptides of gene and gene segments from the genome pr...

Numab

Founded in 2011, Numab discovers and develops innovative antibody-based therapeutics. Applying proprietary rabbit-based antibody discovery and engineering technology, Numab generates highly potent and stable antibody Fv fragments, which serve as building blocks to create mono- or bi-specific antibody fragment-based therapeutics with tailored pharmacokineti...

AbCellera Biologics, Inc.

AbCellera is a privately held company that develops next-generation monoclonal antibody therapies and provides enabling technologies to biotechnology and pharmaceutical partners. AbCellera’s lead technology is a proprietary single-cell antibody discovery and immune profiling platform that allows for high-throughput screening of natural immune repertoi...

PRF&L

We provide researchers with high quality, reliable, custom antibody production services by recognizing that the humane care and use of the animals is essential to animal well-being as well as the quality of the services offered. Since our inception in 1960, Major Academic Institutions, Nobel Prize Laureate sponsored laboratories, Major Pharmaceutical and Biotech companies have used Pocono Rabbit F...

f-star

F-star is a biopharmaceutical company dedicated to developing novel bispecific antibody products that provide a significant improvement over the current standard of care. Given its strong patent position, it is the only biopharmaceutical company with the ability to create and develop Fcab™ antibody fragments, and bispecific antibodies, by modifying th...

AbCheck s.r.o.

AbCheck discovers and optimizes human antibodies leveraging several proprietary platforms including in vitro and in vivo technologies. We use phage/yeast display libraries (AbSieve), mass humanization and antibody optimization (AbAccel) to provide high quality leads. Our technology platform can be used in conjunction with all antibody designs and allows se...

SRU Biosystems, Inc

SRU Biosystems, a Woburn, MA based biotechnology firm, is developing high-throughput sensing and molecular biology technologies for rapidly screening the interactions of large genomic, protein, peptide, or antibody libraries against a wide range of biochemical targets. The SRU BIND™ Biosensor technology represents a fundamental advance in the ability to monitor label-free biochemical interaction...

Isogenica Ltd and Fusion Pharmaceuticals Inc

Isogenica is a drug discovery platform-licensing company focusing on the design and build of diverse, fully synthetic, antibody libraries for use in biopharmaceutical discovery. Partners can access an advanced camelid single-domain antibody library (llamdA™) and state-of-the-art, fully synthetic and highly diverse human Fab antibody libraries (Alexandriaâ„...

Vincogen Corporation

Vincogen Corporation is a RF ID Biochip company established in year 2000 and has developed a proprietary radio-frequency (RF) biochip platform and T4 Phage Display platforms for use in several applications across the diagnostic and pharmaceutical industries. In order to achieve the goal of Personalized Medicine, we are co-developing RFID chip (semi-conductor part) and T4 phage display (Bio part)...

Syrrx Incorporated

Syrrx, Inc. is a drug discovery company committed to redefining the way medicines are discovered. Based in San Diego, CA, the company is at the forefront of high-throughput rational drug discovery. Syrrx intends to leverage high-throughput structure determination, high-throughput screening, combinatorial and medicinal chemistry together with computational methods to discover novel small molecule p...

Affitech AS

Affitech A/S is a human antibody medicines company based on modern phage display technology coupled with powerful antibody screening and selection systems. In particular the Company has developed specialized expertise (i) to identify and engineer successful new proprietary human antibodies with improved properties over commercially marketed antibody drugs; and (ii) to isolate effective new ant...

Bangs Laboratories Incorporated

Our new ProActive® protein-coated microspheres are getting rave reviews from customers doing immunoassays, molecular biology and cell work. These generic solid phases dramatically simplify binding to beads, continuing our tradition of supplying only the best microspheres available in the world. (Ask for TechNote #51 for a complete overview and tips on using all of our ProActive® products.) ...

CellPro Incorporated

CellPro Incorporated has developed a unique monoclonal antibody-based system that can be used to separate specificcells from complex cell mixtures for use in a wide range of therapeutic, diagnostic and research applications. The CellPro technology selects cells in a continuous flow system by using a high affinity avidin-biotin binding process. As a result, it combines high levels of throughput wit...

ProSciTech

Our immunogold products are prepared using the highest quality antibodies and binding agents. All antibodies and antibody fragments have been immuno-affinity purified and immuno-cross adsorbed to minimise aspecific reactions. Specialist microscopy supplier.

Phage Biotechnology Corp

Phage Biotechnology Corporation (Phage) is a Delaware Corporation, incorporated in 1998 and headquartered in Las Vegas, Nevada. The company has a manufacturing plant in Irvine, California, with research and development laboratories in Kiev, Ukraine. Currently Phage has approximately 75 employees worldwide. The Company was initially formed to manufacture recombinant protein pharmaceuticals as “ge...

HiFiBiO SAS

HiFiBiO SAS is advancing an innovative and integrated discovery engine that creates unparalleled opportunities for discovering novel, differentiated therapeutic antibodies against complex targets. The platform combines high throughput, single cell, functional-based screening of entire B cell populations with barcoded next generation sequencing and rapid DN...

Cytocentrics AG

CYTOCENTRICS was founded in 2001 as spin-off of the NMI - Natural and Medical Sciences Institute - at the University of Tuebingen in Reutlingen. We provide high throughput and high quality patch clamping to assist drug screening of ion channel targets. Our products centre on high throughput secondary screening, assay development and safety pharmacology.

AgriSera AB

AgriSera is a privately owned Swedish company that provides complete polyclonal and monoclonal antibody production services. Since 1980 we have developed a range of reliable, high-quality antibody production and purification methods. Our main aim is to assist our customers during the complete process of antibody production and to offer continuous support during further antibody characterisation.

AnaptysBio, Inc.

Founded in 2005, AnaptysBio, Inc is a privately-held therapeutic antibody product company and the leader in the use of somatic hypermutation, or SHM, for antibody discovery and optimization. SHM is the body’s natural process for generating potent antibodies to fight disease. The Company’s SHM-Platform™ utilizes the key components of SHM and ...

Phage Biotech Ltd.

Phage-Biotech Ltd. was incorporated in March 2000, as a new player in the emerging field of Phage Therapy. The Company’s mission is to develop proprietary Phage-based anti-infective therapeutics to combat the increasing number of antibiotic-resistant infections worldwide. The Company has two short-term strategic objectives:To identify and formulate proprietary topical Phage preparations from dis...


More From BioPortfolio on "High throughput reformatting phage displayed antibody fragments IgGs"

Quick Search

Corporate Database Quicklinks